Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- Difference Between BG and LUT Under DGFT for Exporters: Complete 2026 Guide
- Cases Where Bank Guarantee Is Exempted for Advance Authorisation | 2026 Guide
- Advance Authorisation vs EPCG Scheme: Which Is Better for Exporters in 2026?
- How to Apply for EPCG License in India: Complete Step-by-Step Guide (2026)
- How to Apply for AEO Certification in India: Complete Step-by-Step Guide (2026)
- Top LMPC Registration Rejection Reasons and How to Avoid Them in 2026
- LMPC Certificate for Imported Pre-Packaged Commodities | Complete Guide 2026
- Exporting to Oman? DGFT Makes eCoO Mandatory Under India–Oman CEPA – Complete Guide (2026)
FeATURED ARTICLES
SARAL SIMS for Steel Imports in India – Complete Guide The Government of India has introduced SARAL SIMS (Simplified Steel…
Top Export Compliance Mistakes: DGFT Advance Authorization, EPCG & CPCB (2025 Guide) Exporting in India can feel like a legal…
Environmental Clearance CPCB: Quick Guide for Exporters If you’re an Indian exporter or manufacturer working under schemes like the Advanced…
DGFT e-BRC Rule 2025: Key Update for Advance Authorization & EPCG Holders The Directorate General of Foreign Trade (DGFT) has…


